Transcript Module 5 - Recording and monitoring of HPV vaccine pptx, 805kb

Essential Training Package for HPV Vaccine Introduction
Module 5
Recording and monitoring of
HPV vaccine
CervarixTM
Learning objectives
 At the end of the module, you will have learned to:
– Define process of monitoring HPV vaccine coverage
data
– Describe the 4 main monitoring tools at service
delivery level
– Describe the procedure to monitor AEFIs
 Duration
– 25’
2|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Key issues
1
What is the process for HPV vaccine
coverage monitoring?
2
How to use the monitoring tools?
3
What is the process for AEFI monitoring
and reporting?
3|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Flowchart of HPV vaccine coverage
monitoring process and tools
1 - Service delivery/site level
(i.e. point of vaccine delivery)
Record each vaccinated girl
by year of age and by dose number
1- Immunization cards
(fill out one tally sheet/vaccination day)
2- Immunization register
Sum up tally sheets
Report numbers of doses given by year of
age and by dose number to district
2 - District level
3 - Country level
4|
Data collection &
reporting tools
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
3-Tally sheet
4- Monthly report
HPV vaccine coverage
data collection procedure
Key steps
Tools
1
Register each eligible girl
Immunization register
2
Complete the girl’s immunization card
Immunization card
3
Tally the number of dose given, by dose
number & by year of age (per vaccination)
4
Calculate sub-totals of HPV doses given, by
dose number & by year of age (at the end of
each vaccination session)
5
Report the sub-totals to service delivery site
5|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Tally Sheet
Monthly record sheet
Monitoring tool 1: Immunization card
 HPV vaccination should always be recorded in the
appropriate immunization card
 Girls and Health Workers need to understand the importance
of the card and how to handle it
6|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
What should you do in this scenario?
The girl does not bring her HPV
immunization card
How should you record the
vaccination given?
7|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Monitoring tool 2: Immunization register
Use one register per
service delivery site
District:
Town/Village:
Service delivery site:
Name
Address
DOB
(dd/mm/yyyy)
HPV1
Date Given
(dd/mm/yyyy)
HPV2
Age of girl
(years)
Date Given
(dd/mm/yyyy)
Comments
Age of girl
(years)
 Record the details of each girl in the register
 When a girl returns for HPV2 use her card to locate her entry in the register
 Use register to follow up with girls that did not return for 2nd dose of HPV
vaccine
8|
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Monitoring tool 3: Tally sheet
Record the number (No.) of HPV doses given on a single vaccination day
Date of vaccination (DD/MM/YYYY):
01/01/2010
Age (years)
No. of HPV1 doses given
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
9
10
11
12
13
14
≥15
Unknown
OPTIONAL CHECK ROW
(sum up columns)
9|
District:
Town/Village:
Service delivery site:
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
OPTIONAL CHECK COLUMN
(sum up rows)
No. of HPV2 doses given
9yrHPV1=
8
10yrHPV1=
0
11yrHPV1=
12yrHPV1=
13yrHPV1=
14yrHPV1=
15yrHPV1=
UknHPV1=
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
9yrHPV2=
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
00000
=
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
10
=
10yrHPV2=
15
=
11yrHPV2=
=
12yrHPV2=
=
13yrHPV2=
=
14yrHPV2=
=
15yrHPV2=
=
UknHPV2=
=
=
Grand total =
Monitoring tool 4: Monthly Record Sheet
Month/Year of report:
01/2014
District:
Town/Village:
Service delivery site:
Comments
No. of HPV2 doses given
No. of HPV1 doses given
Age (years)
9yrHPV2:
9yrHPV1:
Total
Total
9
10
8
10yrHPV2:
10yrHPV1:
10
Total
Total
15
0
11yrHPV2:
11yrHPV1:
11
Total
Total
12yrHPV2:
12yrHPV1:
12
Total
Total
13yrHPV2:
13yrHPV1:
13
Total
Total
14yrHPV2:
14yrHPV1:
Total
Total
14
15yrHPV2:
15yrHPV1:
≥15
UknHPV2:
UknHPV1:
Unknown
10 |
Total
Total
Total
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Total
Using data to improve
HPV vaccine coverage
 Compare doses given to the target population by year
(e.g. no. of 9 year old girls that received HPV1 dose
versus no. of 9 year old girls in the catchment area) and
consider:
– Are there groups of girls that are not reached?
– Are girls in the right age group being vaccinated?
 Compare number of HPV1 doses administered with
number of HPV2 doses administered and consider
– Are there problems with communication, vaccine availability,
etc. causing drop-outs?
– Identify and vaccinate defaulters
11 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Considerations of AEFI
related to HPV vaccine
 HPV vaccine is a safe vaccine but mild adverse events
can occur after administering the vaccine
– Redness, pain or swelling at the injection site
– Syncope (fainting)
 In extremely rare instances it can cause anaphylaxis
– One per 1.7 million doses
 Girls should be observed carefully for 15 minutes after
administration of vaccine
 Manage and document any adverse reaction accordingly
to the national reporting procedures
12 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Procedure for AEFI reporting
 Report AEFIs through existing AEFI reporting systems
established by national immunization programs
Suspected signs
or symptoms
1
13 |
Health worker should
immediately report to a
local public health
authority
2
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
National
Authorities will then
decide if futher
investigation is required
3
AEFI reporting form
 AEFI report should contain
Details of Patient
Reporter details
Details of Vaccine
Details of the event
14 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Key messages (1/2)
Monitoring vaccine coverage
 Monitoring and reporting HPV vaccine coverage is crucial for evaluating
the performance of the immunization programme and its impact on the
vaccinated girls
 HPV vaccine coverage should be monitored by year of age and by dose
number
 Vaccine coverage should be monitored with a set of tools including
immunization card, register, tally sheet, and monthly report form.
 The process for monitoring vaccine coverage data includes 5 steps
2. Using
3. registering
1.Registering
girls details immunization given dose
card
per age
15 |
4. Calculate sub-totals 5. Report Sub-totals
of HPV dose given
to service delivery site
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
Key messages (2/2)
Monitoring AEFI related to HPV vaccine
 Monitoring and reporting AEFI related to HPV vaccine is
essential for dispelling rumors and monitoring continued
safety of HPV vaccines
 AEFI should be reported using the existing system
established by the national immunization program
 Suspected AEFI related to HPV vaccine should be
reported immediately to reporting authorities
 The AEFI reporting form should contain details of patient,
event, vaccine and reporter details
16 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
End of module
Thank you
for your attention!
17 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016
References
 Comprehensive Cervical Cancer Control. A guide to
essential practice (C4 GEP). WHO 2014
 HPV vaccine introduction into national immunization
programmes: Information for programme managers and
health workers. WHO 2014
 Human Papillomavirus (HPV) Vaccine Coverage
Monitoring Tool. WHO 2014
18 |
Recording and Monitoring of HPV Vaccine, Module 5 CervarixTM I 24 July
2016